The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 5.00 (0.29%)
Spread: 0.50 (0.029%)
Open: 1,733.00
High: 1,739.50
Low: 1,724.50
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BUZZ-U.S. Stocks on the Move-Ciena, Matrix, Methode, Mitek

Thu, 04th Sep 2014 14:59

(For faster updates on individual market-movers, Eikon usersplease use search string "STXBZ US"; for more market insights,including options activity, ; for the Day Aheadnewsletter, http://link.reuters.com/mex49s; for the Morning NewsCall newsletter, http://link.reuters.com/nex49s)

U.S. stocks opened slightly higher on Thursday, after theEuropean Central Bank cut interest rates to record lows and aflurry of economic data indicated the U.S. economy was steadilyimproving. The Dow Jones industrial average was up 0.37percent at 17,141.74, the S&P 500 was up 0.47 percent at2,010.16 and the Nasdaq Composite was up 0.2 percent4,581.71.

** AMAZON.COM INC, $347.65, +2.55 pct

Sanford C. Bernstein raised its price target on the stock ofthe online retailer to $450 from $360. "Amazon has built abetter, more cost-effective retail model than the vast majorityof brick-and-mortar retailers," Bernstein analysts said in anote. The median price target on stock is $400, according toThomson Reuters data.

** AEROVIRONMENT INC, $32, -4.90 pct

The drone maker reported a first-quarter loss of 16 centsper share, wider than the average analysts' estimate of 11cents, according to Thomson Reuters I/B/E/S

** NORDSTROM INC, $70.66, +1.46 pct

The apparel retailer authorized a $1 billion sharerepurchase. The latest buyback excludes $323 million remainingunder earlier plan.

** TASER INTERNATIONAL INC, $17.95, +7.23 pct

The stun gun maker received multiple orders from theCleveland police department for its Taser brand smart weapons.The company did not disclose the financial terms.

The stock had gained about 35 percent since Aug. 8, a daybefore fatal shooting in Ferguson, Missouri, through Wednesday.

** METHODE ELECTRONICS INC, $39.58, +15.53 pct

The electronic component maker said it expects full-yearprofit of $2.10-$2.20 per share on revenue of $870 million-$885million, up from prior forecast of a profit of $1.85-$2 pershare on revenue of $835 million-$860 million. MethodeElectronics reported a better-than-expected first quarterresults, helped by higher sales and better margins in itsautomotive unit.

The company's shares rose 16.5 percent to a 14-year-high of$40.

** IRONWOOD PHARMACEUTICALS INC, $12.39, -4.62 pct

Cowen & Co lowered its rating on the drugmaker's stock to"market perform" from "outperform", citing recent physicianfeedback on Ironwood's constipation drug, Linzess. The brokeragealso slashed its price target to $10.50 from $16.00, saying itsconsultants believe adoption of Linzess by general practitionerswill be slow.

** NORTHSTAR REALTY FINANCE CORP, $18.35, -2.65 pct

The real estate investment trust priced its offering of 45million shares at $18.40 per share, a discount of 2.4 percent tostock's Wednesday close. The offering represents 22.7 percent ofoutstanding shares as of Aug. 8.

The stock is most traded on New York Stock Exchange onThursday. Deutsche Bank Securities Inc will borrow and sell 22.5million shares to underwriters in the offering.

** SHOE CARNIVAL INC, $19.64, -11.37 pct

The footwear retailer reported lower-than-expected secondquarter sales and profit as fewer customers visited its storesand expenses rose. Its profit has now missed estimates for thelast three quarters. The company forecast third quartercomparable-store sales to either decline up to 1 percent or growup to 1 percent.

Susquehanna Financial Group analysts cut price target to $24from $25 on the stock which had fallen 24 percent this year upto Wednesday's close.

** SOLARCITY CORP, $70.8244, +4.58 pct

The solar panel installer said it would open 20 newoperations centers in seven U.S. states. The company, backed byTesla Motors Inc founder Elon Musk, says new centersexpected to create more than 600 additional jobs.

** BAZAARVOICE INC, $7.9808, +6.41 pct

B. Riley & Co raises price target on stock of the softwaremaker to $10 from $9.75, saying net new client additions in Q1were significantly higher than it had estimated.

Bazaarvoice, which provides businesses online and socialmedia tools to interact with customers, reportedhigher-than-expected Q1 revenue and smaller-than-expected losson Wednesday

** VERIFONE SYSTEMS INC, $35.93, +4.02 pct

The credit card swipe machine maker raised full-year revenueforecast for the third time, encouraged by strong sales ofdevices that can accept chip-embedded credit cards. VeriFonealso raised full-year profit forecast and reportedbetter-than-expected third quarter revenue.

The company is benefiting as U.S. retailers upgrade theirpoint-of-sale terminals to systems compatible with more securecredit cards in the wake of several data breaches. Up toWednesday's close, the stock had risen nearly 30 percent thisyear.

** ARLINGTON ASSET INVESTMENT CORP, $27.197, -4.20pct

The mortgage investor said it was offering 2.75 millionshares of Class A common stock - 14 percent of its totaloutstanding shares - at $27.61 each, a 2.7 pct discount toWednesday's close.

Arlington said it plans to use the proceeds to acquireassets. Up to Wednesday's close, the stock had risen 7.6 percentthis year.

** STEREOTAXIS INC,$3.35, +17.54 pct

The medical device maker received U.S. FDA's marketingapproval for its device used during procedures to assess heartactivity. The device, called Vdrive Robotic Navigation System,is designed to remotely control catheter during such procedures.

** KAMADA LTD, $5.75, -19.69 pct

The Israel-based drugmaker's experimental drug to treat aninherited condition that raises the risk of lung and liverdisease failed in a mid-stage study. The drug, Inhaled Alpha-1Antitrypsin, did not show a statistically significantdifference, compared with a placebo. Glassia, an intravenousversion of the drug, is already being marketed by Baxter Inc in the United States.

** CIENA CORP, $18.76, -8.31 pct

The network equipment forecast fourth quarter revenue of$570 million-$610 million, below the average analyst estimate of$628.9 million. The company said it expects fourth quarteradjusted gross margin in the high 30s to low 40s percent range.

** MITEK SYSTEMS INC, $3.55, +49.79 pct

The mobile imaging software maker agreed on Wednesday tosettle all pending litigation with financial services group USAAover five of its patents relating to image capture on mobiledevices. Mitek's lawsuit filed in 2012 also included allegationsof misappropriation of trade secrets, breach of contract andfraud. The company said neither party will make any payment oradmit liability on any claims.

** GOPRO INC, $54.4, -4.33 pct

J.P. Morgan cut its rating on the stock of the maker of camera makers to "neutral" from "overweight", saying the stockis trading above its price target of $51. The median pricetarget on stock is $46.50. Of nine analysts covering the stock,2 have "buy" ratings and 7 have "hold" or equivalent ratings. Upto Wednesday's close, the stock had risen 137 percent since itsdebut on June 26.

** MEMORIAL PRODUCTION PARTNERS LP, $22.42, -3.20pct

The oil and gas producer said it would offer 13 millioncommon units; representing 18 percent of outstanding shares asof Wednesday. The company said it plans to use net proceeds fromthe underwritten public offering to pay down debt.

** MATTRESS FIRM HOLDING CORP, $63.41, +11.62 pct

The company said it would buy privately held beddingretailer The Sleep Train Inc for $425 million, its sixth andlargest acquisition announced in the past year, to expand itspresence on the West Coast.

** NEWLINK GENETICS CORP, $26.79, +3.16 pct

NewLink Genetics said the U.S. Food and Drug Administrationallowed the company to start testing an experimental Ebolavaccine in humans.

The move follows a decision to begin initial human testingof a GlaxoSmithKline vaccine this month and an approvalto fast track tests of a Johnson & Johnson vaccine.

** TIBCO SOFTWARE INC, $21.9101, +4.14 pct

The business software maker said it was reviewing itsstrategic and financial alternatives as part of a processinitiated by its board on Aug. 16 to maximize shareholder value. The company has formed a special committee of independentdirectors to undertake the review.

** MATRIX SERVICE CO, $22.7, -22.07 pct

The engineering and construction services provider's fourthquarter revenue and profit missed analysts' estimates due to a47 percent rise in costs. Revenue from the company's oil, gasand chemical segment, which provides construction andmaintenance services to North American oil producers, fell about22 percent to $52.1 million. Matrix also forecast full-yearearnings below estimates.

** PVH CORP, $128.12, +9.38 pct

The apparel company's second quarter profit beatexpectations, helped by strong sales of its TommyHilfiger-branded clothes. PVH cut its full-year revenue forecastto $8.4 billion from $8.5 billion, but it reaffirmed its profitforecast. (Compiled by Rohit T.K. in Bangalore; Editing by Joyjeet Das)

More News
16 Jan 2024 17:04

GSK to sell GBP1 billion worth of Haleon shares as trims stake again

(Alliance News) - GSK PLC on Tuesday said it intends to sell around GBP1.00 billion worth of shares in Haleon PLC, as it continues to reduce its shareholding in the Weybridge, Surrey-based consumer healthcare spin-off.

Read more
16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
16 Jan 2024 08:15

UBS downgrades AstraZeneca to 'sell'

(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.

Read more
16 Jan 2024 07:37

LONDON BRIEFING: UK jobless rate sticks at 4.2% but pay growth slows

(Alliance News) - Stocks in London are called to open lower on Tuesday, following data showing that the UK jobless rate was unchanged at 4.2% as pay growth slowed.

Read more
15 Jan 2024 08:42

Zantac fallout unfairly weighing on GSK, says Shore Capital

(Sharecast News) - Shore Capital has raised its target price and maintained a positive stance on biopharma giant GSK, saying that worries about the potential cost of Zantac litigation are unfairly weighing on the stock.

Read more
10 Jan 2024 09:35

LONDON BROKER RATINGS: BofA cuts Ashtead; UBS likes 3i Group

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
10 Jan 2024 08:25

GSK says Nucala gets green light in China for asthma treatment

(Alliance News) - GSK PLC on Wednesday said Nucala has been approved in China for the treatment of severe asthma.

Read more
10 Jan 2024 07:22

GSK's Nucala gets fresh approval in China

(Sharecast News) - GSK announced on Wednesday that the China National Medical Products Administration (NMPA) has granted approval for 'Nucala', or mepolizumab, as an add-on maintenance treatment for severe eosinophilic asthma in adults and adolescents aged 12 years and older.

Read more
9 Jan 2024 16:22

London close: Stocks finish red after choppy session

(Sharecast News) - London stocks had turned back into the red by the close on Tuesday, with recruitment firms and asset managers pacing the declines after some disappointing corporate updates.

Read more
9 Jan 2024 08:03

TOP NEWS: GSK to buy Aiolos Bio for up to USD1.4 billion

(Alliance News) - GSK PLC on Tuesday said it will acquire asthma drug developer Aiolos Bio Inc for USD1 billion upfront, as well as up to USD400 million in certain success-based milestone payments.

Read more
9 Jan 2024 07:16

GSK buys respiratory drug maker Aiolos for $1bn

(Sharecast News) - GSK said it was buying Aiolos, a clinical-stage biopharmaceutical company focused on treatment of respiratory and inflammatory conditions, for up to $1.4bn (£1.1bn).

Read more
8 Jan 2024 23:39

Pfizer to remain aggressive on obesity market after setback

NEW YORK, Jan 8 (Reuters) - Pfizer will remain aggressive in trying to break into the lucrative obesity market, even after dropping a high profile weight-loss drug candidate late last year due to strong side effects, Chief Executive Albert Bourla said on Monday.

Read more
8 Jan 2024 23:00

Pfizer to remain aggressive on obesity market after setback

NEW YORK, Jan 8 (Reuters) - Pfizer will remain aggressive in trying to break into the lucrative obesity market, even after dropping a high profile weight-loss drug candidate late last year due to strong side effects, Chief Executive Albert Bourla said on Monday.

Read more
8 Jan 2024 19:02

Moderna says it hit its 2023 COVID vaccine sales goal

Jan 8 (Reuters) - Moderna on Monday said its 2023 COVID vaccine sales would be around $6.7 billion, coming in above the lower end of its full-year forecast, and reiterated its goal of returning to sales growth in 2025.

Read more
4 Jan 2024 14:01

UK dividends calendar - next 7 days

Friday 5 January 
British Land Co PLCdividend payment date
Hill & Smith PLCdividend payment date
JD Sports Fashion PLCdividend payment date
JPMorgan Global Growth & Income PLCdividend payment date
Liontrust Asset Management PLCdividend payment date
Lok'n Store Group PLCdividend payment date
Real Estate Credit Investments Ltddividend payment date
RS Group PLCdividend payment date
Tate & Lyle PLCdividend payment date
Monday 8 January 
abrdn Equity Income Trust PLCdividend payment date
Intermediate Capital Group PLCdividend payment date
Tuesday 9 January 
no events scheduled 
Wednesday 10 January 
Assura PLCdividend payment date
Bellway PLCdividend payment date
Fidelity Special Values PLCdividend payment date
LXi REIT PLCdividend payment date
Severn Trent PLCdividend payment date
Volex PLCdividend payment date
Vp PLCdividend payment date
Thursday 11 January 
AJ Bell PLCex-dividend payment date
Ashtead Group PLCex-dividend payment date
BlackRock Latin American Investment Trust PLCex-dividend payment date
CMC Markets PLCdividend payment date
dotdigital Group PLCex-dividend payment date
Ecora Resources PLCex-dividend payment date
European Assets Trust PLCex-dividend payment date
Foresight Group Holdings Ltdex-dividend payment date
GSK PLCdividend payment date
ICG-Longbow Senior Secured UK Property Debt Investments Ltdex-dividend payment date
JPMorgan Asia Growth & Income PLCex-dividend payment date
Keystone Positive Change Investment Trust PLCex-dividend payment date
LondonMetric Property PLCdividend payment date
Murray International Trust PLCex-dividend payment date
National Grid PLCdividend payment date
Primary Health Properties PLCex-dividend payment date
Sage Group PLCex-dividend payment date
Smiths News PLCex-dividend payment date
SSE PLCex-dividend payment date
Supermarket Income REIT PLCex-dividend payment date
TR Property Investment Trust PLCdividend payment date
Walker Crips Group PLCex-dividend payment date
WH Smith PLCex-dividend payment date
Worldwide Healthcare Trust PLCdividend payment date
XPS Pensions Group PLCex-dividend payment date
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.